Median age (range)
| |
52.0 (43.0–60.8)
| |
50.0 (42.0–54.0)
| |
66.0 (60.0–68.0)
| |
< 0.001
|
Median tumor size (cm) (range)
| |
2.0 (1.4–2.9)
| |
2.0 (1.4–2.8)
| |
2.1 (1.4–3.6)
| |
0.275
|
Median BMI (kg/m2) (range)
| |
24.8 (23.5–27.7)
| |
26.7 (24.2–28.6)
| |
23.0 (21.9–24.2)
| |
< 0.001
|
Median TAT (mm2) (range)
| |
29,205 (24,937–37,647)
| |
31,005 (26,140–39,174)
| |
26,400 (20,232–27,316)
| |
< 0.001
|
Median SAT (mm2) (range)
| |
13,268 (10,127–17,695)
| |
13,422 (10,127–18,016)
| |
13,268 (11,218–17,042)
| |
0.609
|
Median VAT (mm2) (range)
| |
15,982 (11,302–19,879)
| |
18,244 (14,495–20,584)
| |
10,176 (4626–14,048)
| |
< 0.001
|
Median VAT% (range)
| |
51.4 (42.9–62.5)
| |
55.0 (48.5–64.4)
| |
40.7 (31.8–51.4)
| |
< 0.001
|
No. comorbid conditions, n (%)
| | | | | | | | |
Hypertension
| |
72 (36.0%)
| |
46 (30.1%)
| |
26 (55.3%)
| |
0.002
|
Hypercholesterolemia
| |
16 (8.0%)
| |
8 (5.2%)
| |
8 (17.0%)
| |
0.026
|
Diabetes
| |
20 (10.0%)
| |
11 (7.2%)
| |
9 (19.1%)
| |
0.025
|
No. smoking status, n (%)
| | | | | | | | |
Never
| |
75 (37.5%)
| |
28 (18.3%)
| |
47 (100.0%)
| |
< 0.001
|
Former
| |
70 (35.0%)
| |
70 (45.8%)
| |
0 (0.0%)
| |
Current
| |
55 (27.5%)
| |
55 (35.9%)
| |
0 (0.0%)
| |
No. alcohol status, n (%)
| | | | | | | | |
Never
| |
69 (34.5%)
| |
30 (19.6%)
| |
39 (83.0%)
| |
< 0.001
|
Former
| |
40 (20.0%)
| |
40 (26.1%)
| |
0 (0.0%)
| |
Current
| |
91 (45.5%)
| |
83 (54.2%)
| |
8 (17.0%)
| |
No. ISUP grade, n (%)
| | | | | | | | |
Low-grade (1–2)
| |
116 (58.0%)
| |
105 (68.6%)
| |
11 (23.4%)
| |
< 0.001
|
High-grade (3–4)
| |
84 (42.0%)
| |
48 (31.4%)
| |
36 (76.6%)
| |